Clinical Trials List
2012-11-01 - 2014-02-28
Phase III
Terminated5
ICD-10J44.9
Chronic obstructive pulmonary disease, unspecified
ICD-9496
Chronic airways obstruction, not elsewhere classified
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 劉世豐 Division of Thoracic Medicine
- 方文豐 Division of Thoracic Medicine
- 張晃智 Division of Thoracic Medicine
- 吳沼漧 Division of Thoracic Medicine
- Chia-Cheng Tseng Division of Thoracic Medicine
- 黃國棟 Division of Thoracic Medicine
- 蘇茂昌 Division of Thoracic Medicine
- 梁深怡 Division of Thoracic Medicine
- 王逸熙 Division of Thoracic Medicine
- 趙東瀛 Division of Thoracic Medicine
- 陳永哲 Division of Thoracic Medicine
- 秦建弘 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 周昆達 Division of Thoracic Medicine
- Kang-Cheng Su Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 鷗亭芸 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
35 participants
-
Global
736 participants
